The arrival of GLP-1 receptor agonists and dual agonists has delivered unprecedented efficacy, reframed obesity as a chronic disease, and sparked an industry gold rush
BreastCancer.org highlighted research suggesting GLP-1 use may help some patients on hormonal therapy lose weight, even though that weight loss may be slower or less dramatic than in the general population
@Biodance_global Radiant Vita Niacinamide Real Deep Mask @costco_canada Calgary Taza March 2026
Pathways implicated in addiction also contribute to pathological overeating and obesity, they write
Recent REDEFINE trials demonstrate superior efficacy
A matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) assay revealed several proteins with antioxidant functions including a GST that were differentially expressed between compatible and incompatible interactions, indicating the differential accumulation of ROS in infected tissues (Li et al., 2011)